Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL2123019 | 0.93 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| Acrylic Acid SCHEMBL3027841 | 0.93 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| Acrylic Acid SCHEMBL1100290 | 0.93 | TSHR (0.63) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL52064 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL25275191 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL25228041 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL25270629 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL20503422 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL7111058 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 | |
| SCHEMBL2098727 | 0.88 | TSHR (0.70) | TSHRALDH1A1CYP3A4HPGDHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8858986-B2 | Biocompatible hydrophilic compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-10-14 | — | — | US | disclosed |
| US-20130190408-A1 | BIOCOMPATIBLE HYDROPHILIC COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2013-07-25 | — | — | US | disclosed |
| EP-2411061-A1 | HYDROPHILIC POLYPROPYLENE MELT ADDITIVES | 3M Innovative Properties Company (US) | 2012-02-01 | — | — | EP | disclosed |
| EP-2291285-A1 | BIOCOMPATIBLE HYDROPHILIC COMPOSITIONS | 3M Innovative Properties Company (US) | 2011-03-09 | — | — | EP | disclosed |
| WO-2010111491-A1 | HYDROPHILIC POLYPROPYLENE MELT ADDITIVES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-09-30 | — | — | WO | disclosed |
| EP-2220150-A1 | METHODS FOR FORMING MICROPOROUS AND ANTIMICROBIAL ARTICLES | 3M Innovative Properties Company (US) | 2010-08-25 | — | — | EP | disclosed |
| WO-2009152345-A1 | BIOCOMPATIBLE HYDROPHILIC COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-12-17 | — | — | WO | disclosed |
| EP-2101572-A2 | BIOCOMPATIBLE ANTIMICROBIAL COMPOSITIONS | 3M Innovative Properties Company (US) | 2009-09-23 | — | — | EP | disclosed |
| WO-2009070630-A1 | METHODS FOR FORMING MICROPOROUS AND ANTIMICROBIAL ARTICLES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-06-04 | — | — | WO | disclosed |
| WO-2008133724-A2 | BIOCOMPATIBLE ANTIMICROBIAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-11-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190408-A1 | BIOCOMPATIBLE HYDROPHILIC COMPOSITIONS | CD44, CD68, EPCAM | TSHR 3734/4885ALDH1A1 2214/4885CYP3A4 4717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.